Caspofungin versus liposomal amphotericin B for empirical therapy.
Jones
Brian L
BL
McLintock
Lorna A
LA
D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use*; D000077336:Caspofungin; D054714:Echinocandins; D005334:Fever / Q000209:etiology; D006801:Humans; D055666:Lipopeptides; D009181:Mycoses / Q000175:diagnosis / Q000188:drug therapy*; D009503:Neutropenia / Q000188:drug therapy / Q000209:etiology; D010456:Peptides, Cyclic / Q000627:therapeutic use; D018570:Risk Assessment
D000935:Antifungal Agents; D054714:Echinocandins; D055666:Lipopeptides; D010456:Peptides, Cyclic; D000666:Amphotericin B; D000077336:Caspofungin